368 related articles for article (PubMed ID: 26786818)
1. Associations between polymyalgia rheumatica and giant cell arteritis and 12 cardiovascular diseases.
Pujades-Rodriguez M; Duyx B; Thomas SL; Stogiannis D; Smeeth L; Hemingway H
Heart; 2016 Mar; 102(5):383-9. PubMed ID: 26786818
[TBL] [Abstract][Full Text] [Related]
2. Incidence of cardiovascular events in polymyalgia rheumatica and giant cell arteritis amongst an Asian population: Propensity score matched cohort study.
Kobayashi D; Suyama Y; Osugi Y; Arioka H; Takahashi O; Kuriyama N
Int J Rheum Dis; 2018 Jun; 21(6):1314-1321. PubMed ID: 29879315
[TBL] [Abstract][Full Text] [Related]
3. Long-term glucocorticoid treatment in patients with polymyalgia rheumatica, giant cell arteritis, or both diseases: results from a national rheumatology database.
Albrecht K; Huscher D; Buttgereit F; Aringer M; Hoese G; Ochs W; Thiele K; Zink A
Rheumatol Int; 2018 Apr; 38(4):569-577. PubMed ID: 29124397
[TBL] [Abstract][Full Text] [Related]
4. COVID-19 outcomes in giant cell arteritis and polymyalgia rheumatica versus rheumatoid arthritis: A national, multicenter, cohort study.
Vieira M; Comarmond C; Labreuche J; Mirouse A; Saadoun D; Richez C; Flipo RM; Hachulla E; Drumez E; Cacoub P;
J Autoimmun; 2022 Oct; 132():102868. PubMed ID: 35926375
[TBL] [Abstract][Full Text] [Related]
5. Risk of fracture among patients with polymyalgia rheumatica and giant cell arteritis: a population-based study.
Paskins Z; Whittle R; Sultan AA; Muller S; Blagojevic-Bucknall M; Helliwell T; Hider S; Roddy E; Mallen C
BMC Med; 2018 Jan; 16(1):4. PubMed ID: 29316928
[TBL] [Abstract][Full Text] [Related]
6. Cardiovascular risk factors associated with polymyalgia rheumatica and giant cell arteritis in a prospective cohort: EPIC-Norfolk Study.
Yates M; Luben R; Hayat S; Mackie SL; Watts RA; Khaw KT; Wareham NJ; MacGregor AJ
Rheumatology (Oxford); 2020 Feb; 59(2):319-323. PubMed ID: 31325308
[TBL] [Abstract][Full Text] [Related]
7. Contemporary prevalence estimates for giant cell arteritis and polymyalgia rheumatica, 2015.
Crowson CS; Matteson EL
Semin Arthritis Rheum; 2017 Oct; 47(2):253-256. PubMed ID: 28551169
[TBL] [Abstract][Full Text] [Related]
8. Polymyalgia rheumatica and giant cell arteritis in older patients: diagnosis and pharmacological management.
Schmidt J; Warrington KJ
Drugs Aging; 2011 Aug; 28(8):651-66. PubMed ID: 21812500
[TBL] [Abstract][Full Text] [Related]
9. Giant cell arteritis and polymyalgia rheumatica in northwestern Turkey: Clinical features and epidemiological data.
Pamuk ON; Dönmez S; Karahan B; Pamuk GE; Cakir N
Clin Exp Rheumatol; 2009; 27(5):830-3. PubMed ID: 19917168
[TBL] [Abstract][Full Text] [Related]
10. Accuracy of self-reported diagnoses of polymyalgia rheumatica and giant cell arteritis in the French prospective E3N- EPIC cohort: A validation study.
Barde F; Ascione S; Pacoureau L; Macdonald C; Salliot C; Boutron-Ruault MC; Seror R; Nguyen Y
Semin Arthritis Rheum; 2024 Feb; 64():152298. PubMed ID: 38000317
[TBL] [Abstract][Full Text] [Related]
11. Serious infections in people with polymyalgia rheumatica (PMR) or giant cell arteritis (GCA): a time-trend national US study.
Singh JA; Cleveland JD
Clin Rheumatol; 2020 Nov; 39(11):3427-3438. PubMed ID: 32399772
[TBL] [Abstract][Full Text] [Related]
12. The spectrum of conditions mimicking polymyalgia rheumatica in Northwestern Spain.
Gonzalez-Gay MA; Garcia-Porrua C; Salvarani C; Olivieri I; Hunder GG
J Rheumatol; 2000 Sep; 27(9):2179-84. PubMed ID: 10990231
[TBL] [Abstract][Full Text] [Related]
13. Familial aggregation of longevity in giant cell arteritis and polymyalgia rheumatica.
Milchert M; Brzosko M
Rheumatol Int; 2020 Dec; 40(12):2071-2075. PubMed ID: 32683496
[TBL] [Abstract][Full Text] [Related]
14. Incidence and Prevalence of Polymyalgia Rheumatica and Giant Cell Arteritis in a Healthcare Management Organization in Buenos Aires, Argentina.
Martínez Perez JM; Mollerach FB; Scaglioni V; Vergara F; Gandino IJ; Catoggio LJ; Rosa JE; Soriano ER; Scolnik M
J Rheumatol; 2023 Jan; 50(1):93-97. PubMed ID: 36243415
[TBL] [Abstract][Full Text] [Related]
15. Polymyalgia rheumatica and its links with giant cell arteritis.
Charlton R
Clin Med (Lond); 2008 Oct; 8(5):498-501. PubMed ID: 18975481
[TBL] [Abstract][Full Text] [Related]
16. Incidence and prevalence of giant cell arteritis and polymyalgia rheumatica: A systematic literature review.
Sharma A; Mohammad AJ; Turesson C
Semin Arthritis Rheum; 2020 Oct; 50(5):1040-1048. PubMed ID: 32911281
[TBL] [Abstract][Full Text] [Related]
17. HLA-DRB1 allele distribution in polymyalgia rheumatica and giant cell arteritis: influence on clinical subgroups and prognosis.
Martínez-Taboda VM; Bartolome MJ; Lopez-Hoyos M; Blanco R; Mata C; Calvo J; Corrales A; Rodriguez-Valverde V
Semin Arthritis Rheum; 2004 Aug; 34(1):454-64. PubMed ID: 15305244
[TBL] [Abstract][Full Text] [Related]
18. Giant cell arteritis and polymyalgia rheumatica: an update.
González-Gay MA; Pina T
Curr Rheumatol Rep; 2015 Feb; 17(2):6. PubMed ID: 25618572
[TBL] [Abstract][Full Text] [Related]
19. Are polymyalgia rheumatica and giant cell arteritis the same disease?
Cantini F; Niccoli L; Storri L; Nannini C; Olivieri I; Padula A; Boiardi L; Salvarani C
Semin Arthritis Rheum; 2004 Apr; 33(5):294-301. PubMed ID: 15079760
[TBL] [Abstract][Full Text] [Related]
20. Concurrent baseline diagnosis of giant cell arteritis and polymyalgia rheumatica - A systematic review and meta-analysis.
Nielsen AW; Frølund LL; Våben C; Bonde AR; Gormsen LC; de Thurah AL; Hauge EM; Keller KK
Semin Arthritis Rheum; 2022 Oct; 56():152069. PubMed ID: 35858507
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]